36022391_Infographic_Xevinapant_Trilynx_Design_Manuscript_v20.1.pdf (2.19 MB)
Download fileInfographic – Summary of the TrilynX phase 3 study design
figure
posted on 17.02.2022, 11:05 by Jean Bourhis, Barbara Burtness, Lisa Francesca Licitra, Christopher M. Nutting, Jonathan D. Schoenfeld, Mokhtar Omar, Florilene Bouisset, Heidi Nauwelaerts, Yulia Urfer, Claudio Zanna, Ezra E.W. CohenXevinapant or placebo plus chemoradiotherapy in
locally advanced squamous cell carcinoma of the head and neck: TrilynX phase 3
study design